“Impact of Lebrikizumab on Patient-Reported Outcomes in Atopic Dermatitis: Prospective and Post Hoc Analyses of a Phase 2b Clinical Trial Demonstrate Clinically Meaningful Improvements”. 2020. SKIN The Journal of Cutaneous Medicine 4 (6): s94. https://doi.org/10.25251/skin.4.supp.94.